Evidence map›Paper›PMID 35140232›Full record

ArticleNature communications2022

Immune signature of acute pharyngitis in a Streptococcus pyogenes human challenge trial.

Jeremy Anderson, Samira Imran, Hannah R Frost, Kristy I Azzopardi, Sedigheh Jalali, Boris Novakovic, Joshua Osowicki, Andrew C Steer, Paul V Licciardi, Daniel G Pellicci

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Lysosomal permeabilization by Group AInfection and immunity · 2026
    Article
  3. Constitutional symptoms and response to Penicillin G in erysipelas and cellulitis - a monocentric, retrospective, explorative study.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Article
  4. Review
  5. Article
  6. Valve biology and rheumatic heart disease pathogenesis.Nature cardiovascular research · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. T cells in Group AFrontiers in cellular and infection microbiology · 2026
    Review
  12. Lysosomal permeabilization by Group AbioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Analysis ofmBio · 2025
    Article
  16. Article
  17. Article
  18. Characterization ofMicroorganisms · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jeremy AndersonMurdoch Children's Research Institute, Melbourne, Australia.
Samira ImranMurdoch Children's Research Institute, Melbourne, Australia.ORCID http://orcid.org/0000-0002-8717-5502
Hannah R FrostMurdoch Children's Research Institute, Melbourne, Australia.
Kristy I AzzopardiMurdoch Children's Research Institute, Melbourne, Australia.
Sedigheh JalaliMurdoch Children's Research Institute, Melbourne, Australia.
Boris NovakovicMurdoch Children's Research Institute, Melbourne, Australia.
Joshua Osowicki *Murdoch Children's Research Institute, Melbourne, Australia. joshua.osowicki@rch.org.au.ORCID http://orcid.org/0000-0002-9432-6700
Andrew C Steer *Murdoch Children's Research Institute, Melbourne, Australia. andrew.steer@rch.org.au.ORCID http://orcid.org/0000-0001-7346-0196
Paul V Licciardi *Murdoch Children's Research Institute, Melbourne, Australia. paul.licciardi@mcri.edu.au.ORCID http://orcid.org/0000-0001-6086-6285
Daniel G Pellicci *Murdoch Children's Research Institute, Melbourne, Australia. dan.pellicci@mcri.edu.au.ORCID http://orcid.org/0000-0001-5305-2398
The University of Melbourne · AUMurdoch Children's Research Institute · AURoyal Children's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pyogenes causes at least 750 million infections and more than 500,000 deaths each year. No vaccine is currently available for S. pyogenes and the use of human challenge models offer unique and exciting opportunities to interrogate the immune response to infectious diseases. Here, we use high-dimensional flow cytometric analysis and multiplex cytokine and chemokine assays to study serial blood and saliva samples collected during the early immune response in human participants following challenge with S. pyogenes. We find an immune signature of experimental human pharyngitis characterised by: 1) elevation of serum IL-1Ra, IL-6, IFN-γ, IP-10 and IL-18; 2) increases in peripheral blood innate dendritic cell and monocyte populations; 3) reduced circulation of B cells and CD4+ T cell subsets (Th1, Th17, Treg, TFH) during the acute phase; and 4) activation of unconventional T cell subsets, γδTCR + Vδ2+ T cells and MAIT cells. These findings demonstrate that S. pyogenes infection generates a robust early immune response, which may be important for host protection. Together, these data will help advance research to establish correlates of immune protection and focus the evaluation of vaccines.

Indexed as

AdultAntigens, BacterialChemokinesCytokinesFemaleHumansMaleMucosal-Associated Invariant T CellsPharyngitisStreptococcal InfectionsStreptococcus pyogenesTh17 CellsT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsAntigens, BacterialChemokinesCytokines

Identifiers

PMID35140232
PMCPMC8828729
OpenAlexW4210886307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.